BUY Laurus Labs Ltd — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred 1–3 months)16 Oct 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
NewsEt-Markets·16 Oct · 3d ago
4 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · adjacent horizon·16 Oct · 4d ago
2 other SEBI-registered advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·13 Oct · 6d ago
Q2 FY27 results scheduled — board meets 29 Oct 2026
BSE · Board Meeting·In 9 days
Laurus Labs invested INR 1.078 billion in its joint venture KRKA Pharma Private Limited via a rights issue, maintaining its 49% stake.
BSE · Company Update·14 Oct · 5d ago
Nifty could fall further unless oil prices ease or Q2 earnings bring relief, says JM Financial analyst
NewsCnbc-Tv18·25 Sept · 3w ago
Buy, Sell Or Hold: L&T, Infosys, HAL, Bajaj Housing And Laurus Labs— Ask Profit
NewsNdtv-Profit·21 Sept · 4w ago
MACD below its signal line — bearish momentum
Technicals · macd·20 Oct · today
2 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·25 Sept · 4w ago
1 other SEBI-registered advisor has an active short-term SELL call on this stock
Advisor consensus · same horizon·27 Jul · 3mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Laurus Labs
- BUY — Shivangi Sarda, Motilal Oswal16 Oct 2026 · ~2 weeks · target ₹2,150 · Active
- BUY — Nuvama Wealth16 Oct 2026 · ~1 year · target ₹2,520 · Active
- BUY — Shivangi Sarda, Motilal Oswal13 Oct 2026 · ~3 months · target ₹2,100 · Active
- BUY — Ansh Jogendra Bhilwar13 Oct 2026 · ~2 weeks · target ₹2,155 · SL hit
- BUY — Ashish Bahety, Profitmart Securities12 Oct 2026 · Same day · target ₹2,080 · Expired
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- BUY Mangalore Refinery and Petrochemicals19 Oct 2026 · ~2 weeks · target ₹218 · Active
- BUY Bharat Heavy Electricals14 Oct 2026 · ~3 months · target ₹500 · Active
- BUY The South Indian Bank14 Oct 2026 · ~2 weeks · target ₹55 · Active
- BUY RBL Bank12 Oct 2026 · ~2 weeks · target ₹476 · SL hit
- BUY Lenskart Solutions12 Oct 2026 · ~2 weeks · target ₹796 · Active

